文献速递神经肿瘤

基于WHO ICF框架建立神经肿瘤患者报告结局测量工具的内容效度:RANO-PRO倡议的一部分

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.
PubMed 文献 · Neuro Oncol · 2025-01-01

本研究调查了114例脑肿瘤患者、71名代理人和65名医疗专业人员对148个ICF相关条目的相关性评价,并评估了215个患者报告结局测量工具的内容覆盖度;超过半数工具的内容效度不足,尤其是多维测量工具。

要点

  • 患者和代理人认为最重要的方面包括注意力集中困难、记忆困难、多任务处理和应对压力。
  • 148个调查条目中56个(37.8%)被认为相关。
  • 根据定义不同,35%至49%的患者报告结局测量工具被认为具有足够内容效度(覆盖≥80%)。

核心结论

  • 超过半数已识别的患者报告结局测量工具内容效度不足,尤其是多维测量工具。

研究设计与样本

  • 基于WHO国际功能、残疾和健康分类(ICF)框架开发148条目调查问卷,请脑肿瘤患者、代理人和医疗专业人员对每个条目的相关性进行评分;随后将215个已识别的患者报告结局测量工具中的所有条目与ICF及调查中的相关条目进行链接,并计算内容覆盖百分比。

主要发现

  • 共114例患者、71名代理人和65名来自不同国家的医疗专业人员完成调查。
  • 148个调查条目中56个(37.8%)被认为相关。
  • 患者和代理人提到的最重要方面是注意力集中困难、记忆困难、多任务处理和应对压力。
  • 根据定义不同,35%至49%的患者报告结局测量工具被认为具有足够内容效度(≥80%覆盖)。

关键数值与推荐

  • 条目被认为相关问题的标准:≥25%的患者或代理人或≥50%的医疗专业人员认为该条目是个问题。
  • 足够内容效度定义为覆盖≥80%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Instruments to assess patient-reported outcomes (PRO) should generate high-quality evidence. Reliable PRO evidence is essential to policymakers, in conjunction with outcomes such as survival and radiological response, to understand the net clinical benefit of antitumor treatments. This study aimed to establish the content validity of 215 identified PRO measures used in patients with brain tumors. METHODS: A survey (n = 148 items) was developed reflecting aspects of the WHO International Classification of Functioning, Disability, and Health (ICF) framework. Patients with brain tumors, their proxies, and healthcare professionals (HCPs) were asked to rate each survey item on relevance. An item was considered a relevant issue if ≥25% of the patients or proxies or ≥50% of the HCPs considered that item to be an issue. Next, all items in the identified PRO measures were linked to ICF and relevant items in the survey, and the percentage of content coverage was calculated. RESULTS: In total, 114 patients, 71 proxies, and 65 HCPs from different countries completed the survey. Fifty-six of 148 (37.8%) items in the survey were considered relevant. The most important aspects mentioned by both patients and proxies were difficulty concentrating, difficulty remembering, multitasking, and handling stress. Depending on the definition, between 35% and 49% of PRO measures were considered to have sufficient content validity (≥80% coverage). CONCLUSION: The content validity was insufficient in more than half of the identified PRO measures, particularly multidimensional measures. Future research should investigate whether different approaches to PRO assessment better meet the needs of all stakeholders.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Asogwa OA, Dirven L, Walbert T, et al. Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative. Neuro Oncol. 2025. PMID: 40293144. doi:10.1093/neuonc/noaf108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。